Home > Expertise > Sovereignty > France 2030

France 2030

PIA 4 Agency Consulting firm Experts Specialists Consultancy

Get financing for your project with the “Investing in the Future” program

Since the first Investments for the Future program (PIA), the Alcimed team has supported public and private players in identifying opportunities related to these large-scale plans, responding to calls for projects and their strategic and operational set-up.

    Tell us about your uncharted territory

    You have a project and want to discuss it with our explorers, write us!

    One of our explorers will contact you shortly.


    They trust us

    Logo_carre_ANCT
    Logo_carre_APHP
    Logo_carre_ARS_IDF
    Logo_carre_CNSA
    Logo_carre_Grand_Lyon
    Logo_carre_Hopitaux_de_Toulouse
    Logo_carre_Ministere_Sante_Solidarite
    Logo_carre_Ministere_Economie_Finances
    Logo_carre_Region_Normandie
    Logo_carre_Universite_Evry

    The challenges related to the Future Investment Program France 2030

    The funding associated with the France 2030 programme is substantial: €54 billion has been announced between now and 2030. However, taking advantage of this funding can be a challenge for public and private sector players, as the future investment programme is structured around a variety of strategies, calls for projects and innovation funding schemes that are sometimes difficult to understand. Three main issues stand out for those wishing to seize this unprecedented funding opportunity:

    France 2030 aims to :

    • Continue the transformation of key sectors of our economy through technological innovation
    • Encourage the emergence of new industries in these strategic sectors

    It is therefore important to ensure that the project is aligned with this ambition. In addition, France 2030 is defined by two cross-cutting objectives, namely to devote 50% of its expenditure to decarbonising the economy, and 50% to emerging, innovative players, with no expenditure that is detrimental to the environment.

    What are the funder’s expectations? Is my project in line with national priorities for innovation funding?

    It is not always straight forward to choose which calls for projects to apply for, between certain calls for projects that have already been launched and others that are still to come, for example as part of acceleration strategies or other schemes run at regional level (€500m is managed at this level).

    What is the best scheme to submit your project to?

    Although the expectations that apply to France 2030 are the same regardless of the system selected, particularly in terms of the scientific and technical quality of the project, submitting a winning application means starting to prepare well in advance, checking that you meet all the specific requirements of the system and working hard on the content and form of your application. It’s a demanding exercise in terms of time and analysis. You need to leave some room for manoeuvre before the submission deadline, and surround yourself with the right partners and reviewers.

    What’s the best way to put together your application and increase your chances of success?

      Tell us about your uncharted territory

      You have a project and want to discuss it with our explorers, write us!

      One of our explorers will contact you shortly.


      How we support you in your projects related to the future investment program PIA 4 and France 2030

      Alcimed works at different levels of a PIA 4 and France 2030 project. Upstream of funding, we can help you identify the right funding window, prepare a high added-value project (market study, partner search, etc.) and put together a winning application. Downstream, we can support your project by providing operational assistance (particularly in terms of sales and initial business flow, if necessary), helping you to diagnose your situation and your results, and working to redirect your strategy and roadmap. To do this, we rely on our excellent knowledge of the future investment programs, their funding mechanisms and the expectations of their evaluators, our expertise in putting together successful applications and our experience of the operational realities of the innovation projects we develop. The public-sector players we support in this process are very often research centres and institutes, as well as health establishments.

      What they say

      • TCV_Institut_Curie_miniature_site_EN_min
        Logo_carre_Institut_Curie

        Dr. Amaury Martin

        Directeur adjoint de l’Institut Curie

      Examples of recent projects carried out for our clients in PIA 4, France Relance and France 2030

      • Preparation of applications in response to the call for Hospital University Research projects (RHU) of the Investments for the Future programs

        We have been supporting the preparation of applications submitted by public-private consortia in response to calls for RHU projects (Hospital-University Research) for 5 years. As the right hand of the supported PU-PHs, our teams have helped with over thirty applications since the first wave, with several significant successes.

        We get involved starting from the scoping of the application, with consulting services for the development of the scientific roadmap and the consortium, right up to the submission of the application and the preparation for the oral interview.

      • Definition of the strategy of an Institut Carnot and support for the deployment of its commercial roadmap

        Instituts Carnot are powerful tools for promoting research set up within the framework of previous Investments for the Future programs.

        At Alcimed, we work closely with the Carnot ecosystem, and we support several institutes in their development strategies. We recently redesigned the strategic activity areas of a leading Institut Carnot, based on an in-depth analysis of its skills and its market potential, and we supported the teams to work on their roadmap and their commercial positioning.

        Finally, we also generated an first flow of partnerships, directly taking on a business development function on behalf of the Institut.

      • Identification of opportunities linked to PIA 4 for companies from a large professional federation

        Alcimed deciphered the PIA 4 and the France Relance Plan to identify and analyze the financing mechanisms of interest for the companies of a large professional federation.

        Our team presented over ten mechanisms during a webinar that brought together nearly a hundred participants.

        We also made our recommendations for taking full advantage of these current and future opportunities, both for the companies in this federation and for the federation itself.

      • Opportunity studies and market studies for innovative projects supported by Technology Transfer Acceleration Companies (SATT), created within the framework of the Investments for the Future program

        Alcimed is identified as a leading firm in supporting scientific project leaders from French research laboratories, in particular those supported by SATT (Technology Transfer Acceleration Companies).

        We thus support the innovations of tomorrow at the various stages of their development, from market research to fundraising preparation as well as the generation of a new business flow.

        For example, we work in the life sciences (healthcare, agrifood, biotech), energy, mobility, and digital sectors.

      • Support for the response to the third wave of University Hospital Institutes (IHU) under the France 2030 plan

        Alcimed has worked with several consortia to design, build and deploy large-scale research projects in response to the wave 3 IHU call for projects. More specifically, we help with :

        • Defining the project’s unique and original strategic positioning
        • Challenging the project, bringing a fresh eye and our expertise in putting together large-scale projects
        • Organising the entire methodology and management of the project, mobilising the teams and leading the project
        • Co-constructing a very high-level application file

        We supported the Women’s Cancer IHU, supported by the Institut Curie, PSL University and INSERM, in setting up its project, and are still supporting it in its operational implementation.

      • Support for University Hospital Centres (CHU) in their strategy to set up a health data warehouse

        Alcimed has assisted several university hospitals in defining the strategy for their health data warehouses, and in preparing a response file to the call for projects for “entrepôt de données de santé, wave 2” issued by Bpifrance as part of the France 2030 initiative. The aim of the projects submitted in response to this call for projects is to set up and strengthen a network of hospital health data warehouses to bring together the public and private research and innovation ecosystems. In this way, the hospital data centers will be able to multiply the analysis of massive health data and the development of 5P medicine. Alcimed provided the strategic framework for the university hospitals (governance, partners, mobilized data and related technical solutions, resource persons, etc.). We then oversaw the compilation of the dossier: recommendations with regard to the eligibility criteria, critical proofreading, project mode monitoring of the drafting schedule and coordination of the tasks and the consortium with a view to submitting very high-level specifications. Over the last few years, Alcimed has helped three university hospitals to win the call for health data warehouses projects.

      You have a project?

        Tell us about your uncharted territory

        You have a project and want to discuss it with our explorers, write us!

        One of our explorers will contact you shortly.


        To go further

        Founded in 1993, Alcimed is an innovation and new business consulting firm, specializing in innovation driven sectors: life sciences (healthcare, biotech, agrifood), energy, environment, mobility, chemicals, materials, cosmetics, aeronautics, space and defence.

        Our purpose? Helping both private and public decision-makers explore and develop their uncharted territories: new technologies, new offers, new geographies, possible futures, and new ways to innovate.

        Located across eight offices around the world (France, Europe, Singapore and the United States), our team is made up of 220 highly-qualified, multicultural and passionate explorers, with a blended science/technology and business culture.

        Our dream? To build a team of 1,000 explorers, to design tomorrow’s world hand in hand with our clients.

        Announced in 2020 and with €20 billion over 5 years, PIA 4 is based on two drivers of change: ecological transition (including €3.4 billion for the development of green innovations and technologies such as hydrogen) and the competitiveness of the economy, supported by social and territorial cohesion. It also aims to accelerate innovation across all sectors with strategic and priority investments, as well as sustainable funding for higher education, research and innovation ecosystems. On the healthcare side, the two main areas that benefit from this support are biotherapies and digital health. It is partly funded by the France Relance Plan, a French recovery plan announced in response to the COVID-19 crisis.

        PIA4 and France 2030 are consecutive future investment programs designed to finance innovation in France. The difference lies in the positioning of France 2030, which is designed to create the conditions for the downstream industrialization of innovations in hydrogen, robotics, space and many other fields. The aim of France 2030 is to upgrade France’s industrial base by financing the construction of new factories and production lines.